PET 6-[18F]fluoro-L-m-tyrosine studies of dopaminergic function in human and nonhuman primates

Frontiers in Human Neuroscience

Volumn 1, Issue MAR, 2008, Pages

  Eberling, Jamie L ^a,b   Bankiewicz, Krystof S ^c   O'Neil, James P ^a   Jagust, William J ^a,d  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine; FMT; Patlak; PET

Indexed keywords

EID: 59649118572     PISSN: 16625161     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.09.009.2007     Document Type: Article

References (26)

1. Bankiewicz, K. S., Daadi, M., Pivirotto, P., Bringas, J., Sanftner, L., Cunningham, J., Forsayeth, J. R., and Eberling, J. L. (2006a). Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys. Exp. Neurol. 197, 363-372.
2. Bankiewicz, K. S., Forsayeth, J., Eberling, J. L., Sanchez-Pernaute, R., Pivirotto, P., Bringas, J., Herscovitch, P., Carson, R. E., Eckelman, W., Reutter, B., and Cunningham, J. (2006b). Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol. Ther. 14, 564-570.
3. Bankiewicz, K. S., Oldield, E. H., Chiueh, C. C., Doppman, D. M., Jacobowitz, D. M., and Kopin, I. J. (1986). Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci. 39, 7-16.
4. Cropley, V. L., Fujita, M., Innis, R. B., and Nathan, P. J. (2006). Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol. Psychiatry 59, 898-907.
5. DeJesus, O. T., Endres, C. J., Shelton, S. E., Nickles, R. J., and Holden, J. E. (1997). Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA. J. Nucl. Med. 38, 630-636.
6. Dhawan, V., Ma, Y., Pillai, V., Spetsieris, P., Chaly, T., Belakhlef, A., Margouleff, C., and Eidelberg, D. (2002). Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J. Nucl. Med. 43, 1324-1330.
7. Doudet, D. J., Chan, G. L., Jivan, S., DeJesus, O. T., McGeer, E. G., English, C., Ruth, T. J., and Holden, J. E. (1999). Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine. J. Cereb. Blood Flow Metab. 19, 278-287.
8. Doudet, D. J., McLellan, C. A., Carson, R., Adams, H. R., Miyake, H., Aigner, T. G., Finn, R. T., and Cohen, R. M. (1991). Distribution and kinetics of 3-O-Methyl-6-[18F]fluoro-l-DOPA in the rhesus monkey brain. J. Cereb. Blood Flow Metab. 11, 726-734.
9. Eberling, J. L., Bankiewicz, K. S., Jordan, S., VanBrocklin, H. F., and Jagust, W. J. (1997). PET studies of functional compensation in a primate model of Parkinson's disease. Neuroreport 8, 2727-2733.
10. Eberling, J. L., Cunningham, J., Pivirotto, P., Bringas, J., Daadi, M. M., and Bankiewicz, K. S. (2003). In vivo PET imaging of gene expression in Parkinsonian monkeys. Mol. Ther. 8, 873-875.
11. Eberling, J. L., Jagust, W. J., Taylor, S., Bringas, J., Pivirotto, P., VanBrocklin, H. F., and Bankiewicz, K. S. (1998a). A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Res. 805, 259-262.
12. Eberling, J. L., Jagust, W. J., Taylor, S., Bringas, J., Pivirotto, P., VanBrocklin, H. F., and Bankiewicz, K. S. (1998b). A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes. Brain Res. 805, 259-262.
13. Eberling, J. L., Pivirotto, P., Bringas, J., and Bankiewicz, K. S. (2000). Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Exp. Neurol. 165, 342-346.
14. Eberling, J. L., Pivirotto, P., Bringas, J., and Bankiewicz, K. S. (2004). Comparison of two methods for the analysis of [18F]6-fluoro-L-m-tyrosine PET data. Neuroimage 23, 358-363.
15. Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T., Chaly, T., Robeson, W., Margouleff, D., Przedborski, S., and Fahn, S. (1994). The metabolic topography of Parkinsonism. J. Cereb. Blood Flow Metab. 14, 783-801.
16. Endres, C. J., Swaminathan, S., DeJesus, O. T., Sievert, M., Ruoho, A. E., Murali, D., Rommelfanger, S. G., and Holden, J. E. (1997). Affinities of dopamine analogs for monoamine granular and plasma membrane transporters: implications for PET dopamine studies. Life Sci. 60, 2399-2406.
17. Forsayeth, J. R., Eberling, J. L., Sanftner, L. M., Zhen, Z., Pivirotto, P., Bringas, J., Cunningham, J., and Bankiewicz, K. S. (2006). A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys. Mol. Ther. 14, 571-577.
18. Jordan, S., Eberling, J. L., Bankiewicz, K. S., Rosenberg, D., Coxson, P. G., VanBrocklin, H. F., O'Neil, J. P., Emborg, M. E., and Jagust, W. J. (1997). 6-[18F]fluoro-L-m-tyrosine: Metabolism, PET kinetics, and MPTP lesions in primates. Brain Res. 750, 264-276.
19. Lammertsma, A. A., and Hume, S. P. (1996). Simplified reference tissue model for PET receptor studies. Neuroimage 4, 153-158.
20. Nahmias, C., Wahl, L., Chirakal, R., Firnau, G., and Garnett, E. S. (1995). A probe for intracerebral aromatic amino-acid decarboxylase activity: distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain. Mov. Disord. 10, 298-304.
21. Namavari, M., Satyamurthy, N., Phelps, M. E., and Barrio, J. R. (1993). Synthesis of 6-[18F] and 4-[18F]Fluoro-l-meta-tyrosines via regioselective radiofluorodestannylation. Appl. Radiat. Isot. 44, 527-536.
22. O'Neil, J. P., and VanBrocklin, H. F. (1995). Development of a semi-remote system for the routine production of [18F]6-fluoro-L-meta-tyrosine to study striatal lesions and therapeutic implants in primates. J. Labelled Comp. Radiopharm. 37, 655-657.
23. Pate, B. D., Kawamata, T., Yamada, T., McGeer, E. G., Hewitt, K. A., Snow, B. J., Ruth, T. J., and Calne, D. B. (1993). Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Ann. Neurol. 34, 331-338.
24. Patlak, C. S., and Blasberg, R. G. (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J. Cereb. Blood Flow Metab. 5, 584-590.
25. Vingerhoets, F. J., Snow, B. J., Lee, C. S., Schulzer, M., Mak, E., and Calne, D. B. (1994). Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann. Neurol. 36, 759-764.
26. Wahl, L., Chirakal, R., Firnau, G., Garnett, E. S., and Nahmias, C. (1994). The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J. Cereb. Blood Flow Metab. 14, 664-670.